您当前的位置：

Dexamethasone palmitate

目录号: PL08638 纯度: ≥98.0%

Dexamethasone palmitate (DXP) 是 Dexamethasone (HY-14648) 的前体药物。Dexamethasone palmitate 可用于炎症的研究。

CAS No. :14899-36-6

商品编号	规格	价格	会员价
PL08638-5mg	5mg	¥353.00	请登录
PL08638-10mg	10mg	¥530.00	请登录
PL08638-50mg	50mg	¥5464.00	请登录
PL08638-100mg	100mg	¥2105.00	请登录
PL08638-200mg	200mg	¥2945.00	请登录
PL08638-500mg	500mg	询价	询价
PL08638-10mM*1mLinDMSO	10mM*1mLinDMSO	¥2119.00	请登录
PL08638-1 mL x 10 mM (in DMSO)		¥491.00	请登录

Medlife所售产品仅用于科学研究（非临床研究），非药品不可食用，不可用于人体或动物的临床诊断和治疗，我们不为个人提供产品及服务。产品COA等资料，可至下方“质量控制”中下载。

*注意事项:下单时请联系销售核实产品价格及货期，避免后续产生不便，感谢支持!

加入购物车在线咨询收藏产品大包装询价

中文名称	Dexamethasone palmitate
中文别名	地塞米松棕榈酸酯;1,3-金刚烷二羧酸二甲酯
英文名称	Dexamethasone palmitate
英文别名	Dexamethasone palmitate;9-Fluoro-11b,17,21-trihydroxy-16a-methylpregna-1,4-diene-3,20-dione 21-palmitate;DEXAMETHASOME PALMITATE;Dexamethasone 21-Palmitate;Dexamethasone palmitate (jan);Dexamethasone-21-palmitate;dexapalmitate;DXM-21-palmitate;Limethason;Limethason (tn);Limethasone;Lipotalon;D01615
Cas No.	14899-36-6
分子式	C₃₈H₅₉O₆F
分子量	630.87
包装储存	Powder -20°C 3 years；4°C 2 years
详情描述	Dexamethasone palmitate (DXP) 是 Dexamethasone (HY-14648) 的前体药物。Dexamethasone palmitate 可用于炎症的研究。

产品详情	Dexamethasone palmitate (DXP) 是 Dexamethasone (HY-14648) 的前体药物。Dexamethasone palmitate 可用于炎症的研究。
生物活性	Dexamethasone palmitate (DXP) is a prodrug of Dexamethasone (HY-14648). Dexamethasone palmitate can be used for the research of inflammation.
性状	Solid
体外研究(In Vitro)	Dexamethasone palmitate (100 μg/mL; 48 h) affects cytokines concentration of RAW 264.7 cells. has not independently confirmed the accuracy of these methods. They are for reference only.Cell Viability AssayCell Line
体内研究(In Vivo)	Dexamethasone palmitate (1280 μg; IVT injection once) shows different distribution in ocular tissue at different times. Dexamethasone palmitate (280-1280 μg; IVT injection once) affects VEGF-induced vascular hyperpermeability. has not independently confirmed the accuracy of these methods. They are for reference only.
运输条件	Room temperature in continental US; may vary elsewhere.
储存方式	Powder -20°C 3 years；4°C 2 years
参考文献	[1]. Lorscheider M, et al. Dexamethasone palmitate nanoparticles: An efficient treatment for rheumatoid arthritis. J Control Release. 2019 Feb 28;296:179-189. [2]. Daull P, et al. A preliminary evaluation of dexamethasone palmitate emulsion: a novel intravitreal sustained delivery of corticosteroid for treatment of macular edema. J Ocul Pharmacol Ther. 2013 Mar;29(2):258-69.

溶解度数据	In Vitro: DMSO : 50 mg/mL (79.26 mM; Need ultrasonic)配制储备液

搜索质检报告(COA)

产品使用指南

Data Sheet

[1]. Lorscheider M, et al. Dexamethasone palmitate nanoparticles: An efficient treatment for rheumatoid arthritis. J Control Release. 2019 Feb 28;296:179-189.
[2]. Daull P, et al. A preliminary evaluation of dexamethasone palmitate emulsion: a novel intravitreal sustained delivery of corticosteroid for treatment of macular edema. J Ocul Pharmacol Ther. 2013 Mar;29(2):258-69.

1：一般建议：溶解度为Medlife测试数据，可能与文献描述存在差异。这是由于生产工艺和批次不同产生的正常现象。为了使其更好的溶解，请用37℃加热试管并在超声波水浴中震动片刻。不同批次产品溶解度各有差异，仅做参考，具体以实验方案为准。

2：储存条件：粉末-20°C一般情况可以保存3年，溶于溶剂-80°C一般情况可以保存1年。不同产品及不同批次产品可能存在差异，请细致阅读产品信息，并辅助参考相关文献描述。

Dexamethasone palmitate

相关产品

The molarity calculator equation

The dilution calculator equation